Core Viewpoint - Vanda Pharmaceuticals Inc. is set to release its third quarter 2025 financial results on October 29, 2025, after market close, followed by a conference call to discuss the results and corporate activities [1][2]. Financial Results Announcement - The financial results for Q3 2025 will be announced on October 29, 2025, after the market closes [1]. - A conference call will be held at 4:30 PM ET on the same day to discuss the results [2]. Conference Call Details - Participants can join the conference call by dialing 1-888-596-4144 for domestic calls or 1-646-968-2525 for international calls, using passcode 8728050 [2]. - The call will be broadcast live and archived on Vanda's website, with a recommendation for investors to register at least 15 minutes early [3]. Replay Information - A replay of the conference call will be available starting at 8:30 PM ET on October 29, 2025, until November 5, 2025, at 11:59 PM ET [4]. - The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers, with the same passcode [4]. Company Overview - Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on developing and commercializing innovative therapies to meet high unmet medical needs [5].